Development of hyperandrogenism during treatment with Insulin-like Growth Factor-1 (IGF-I) in female patients with Laron Syndrome

Clinical Endocrinology

Volumn 48, Issue 1, 1998, Pages 81-87

  Klinger, B ^a   Anin, S ^a   Silbergeld, A ^b   Eshet, R ^b   Laron, Z ^a  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C;

ADOLESCENT; ADULT; ANDROGEN THERAPY; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYPERANDROGENISM; INSULIN BLOOD LEVEL; LABORATORY TEST; LARON SYNDROME; OLIGOMENORRHEA; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SEXUAL DEVELOPMENT; VIRILIZATION;

ADOLESCENT; ADULT; ANDROSTENEDIONE; CHILD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLICLE STIMULATING HORMONE; GROWTH DISORDERS; HUMANS; HYPERANDROGENISM; INSULIN; INSULIN-LIKE GROWTH FACTOR I; LUTEINIZING HORMONE; POLYCYSTIC OVARY SYNDROME; RECOMBINANT PROTEINS; TESTOSTERONE;

EID: 0031912373     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1998.00356.x     Document Type: Article

References (46)

1. Amselem, S., Sobrier, M.L., Dastot, F., Duesquenoy, P.H., Duriez, B. & Goossens, M. (1996) Molecular basis of inherent growth hormone resistance in childhood. Bailliere's Clinical Endocrinology and Metabolism, 10, 353-369.
2. Backeljauw, Ph.E., Underwood, L.E. & The GHIS Collaborative Group (1996) Prolonged treatment with recombinant insulin-like growth factor I in children with growth hormone insensitivity syndrome - a clinical research center study. Journal of Clinical Endocrinology and Metabolism, 81, 3312-3317.
3. Barbieri, R.L., Smith, S. & Ryan, K.J. (1988) The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism. Fertility and Sterility, 50, 197-212.
4. Buyalos, R.P. (1995) Insulin-like growth factors: clinical experience in ovarian function. American Journal of Medicine, 98 (suppl 1A), 55-66.
5. Cumming, D.C. & Wall, F.R. (1985) Non-sex hormone-binding globulin-bound testosterone as a marker for hyperandrogenism. Journal of Clinical Endocrinology and Metabolism, 61, 873-876.
6. Gdansky, E., Diamant, Y.Z., Laron, Z., Silbergeld, A., Kaplan, B. & Eshet, R. (1997) Increased number of IGF-I receptors on erythrocytes of women with polycystic ovarian syndrome. Clinical Endocrinology, 47, 185-190.
7. Godowski, P.J., Leung, D.W., Meacham, L.R., Galgani, J.P., Hellmiss, R., Keret, R., Rotwein, P.S., Parks, J.S., Laron, Z. & Wood, W.I. (1989) Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in 2 patients with Laron type dwarfism. Proceedings of the National Academy of Sciences USA, 86, 8083-8087.
8. Goldzieher, J.W. & Green, J.A. (1962) The polycystic ovary. I. Clinical and histologic features. Journal of Clinical Endocrinology and Metabolism, 22, 325-338.
9. Guidice, L.C. (1992) Insulin-like growth factors and ovarian follicular development. Endocrine Reviews, 13, 641-669.
10. Guler, H.P., Schmidt, C. & Zapf, J. (1989) Effects of recombinant insulin-like growth factor I on insulin secretion and renal function in normal subjects. Proceedings of the National Academy of Sciences USA, 86, 2868-2872.
11. Iwashite, M., Mimuro, T. & Watanabe, M. (1990) Plasma levels of insulin-like growth factor I and its binding protein in polycystic ovarian syndrome. Hormone Research, 33, 21-26.
12. Jacobs, H.S. (1996) Polycystic ovary syndrome. Bailliere's Clinical Endocrinology and Metabolism, 10, 193-321.
13. Kanety, H., Karasik, A., Klinger, B., Silbergeld, A. & Laron, Z. (1993) Long-term treatment of Laron type dwarfs with insulin-like growth factor I increases serum insulin-like growth factor - binding protein 3 in the absence of growth hormone activity. Acta Endocrinologica, 128, 144-149.
14. Kanety, H., Silbergeld, A., Klinger, B., Karasik, A., Baxter, R.C. & Laron, Z. (1997) Long-term effects of insulin-like growth factor (IGF)-I on serum IGF-I, IGF-binding protein-3 and acid labile subunit in Laron syndrome patients with normal growth hormone binding protein. European Journal of Endocrinology, in press.
15. Klinger, B. & Laron, Z. (1995) Three year IGF-I treatment of children with Laron syndrome. Journal of Pediatric Endocrinology and Metabolism, 8, 149-158.
16. Laron, Z (1993) Laron syndrome: from description to therapy. Endocrinologist, 3, 21-28.
17. Laron, Z. (1995) Prismatic cases: Laron syndrome (primary growth hormone resistance). From patient to laboratory to patient. Journal of Clinical Endocrinology and Metabolism, 80, 1526-1531.
18. Laron, Z., Anin, S., Klipper-Aubach, Y. & Klinger, B. (1992) Effects of insulin-like growth factor on linear growth, head circumference and body fat in patients with Laron-type dwarfism. Lancet, 339, 1258-1261.
19. Laron, Z., Avitzur, Y. & Klinger, B. (1995) Carbohydrate metabolism in primary growth hormone resistance (Laron syndrome), before and during insulin-like growth factor I treatment. Metabolism, 44 (suppl 4), 113-118.
20. Laron, Z., Blum, W., Chatelain, P., Ranke, M., Rosenfeld, R., Savage, M. & Underwood, L. (1993a) Classification of growth hormone insensitivity syndrome. Journal of Pediatrics, 122, 141.
21. Laron, Z. & Klinger, B. (1994) IGF-I treatment of adult patients with Laron syndrome: preliminary results. Clinical Endocrinology, 41, 631-638.
22. Laron, Z., Klinger, B., Erster, B. & Anin, S. (1988) Effects of acute administration of insulin like growth factor I in patients with Laron-type dwarfism. Lancet, ii, 1170-1172.
23. Laron, Z., Klinger, B., Eshet, R., Kanety, H., Karasik, A. & Silbergeld, A. (1993b) Laron syndrome due to a post-receptor defect: response to IGF-I treatment. Israel Journal of Medical Sciences, 29, 757-763.
24. Laron, Z., Klinger, B., Jensen, L.T. & Erster, B. (1991) Biochemical and hormonal changes induced by one week administration of rIGF-I to patients with Laron type dwarfism. Clinical Endocrinology, 35, 145-150.
25. Laron, Z., Kowaldo-Silbergeld, A., Eshet, R. & Pertzelan, A. (1990) Growth hormone resistance. Annals of Clinical Research, 12, 269-277.
26. Laron, Z., Pertzelan, A. & Karp, M. (1968) Pituitary dwarfism with high serum levels of growth hormone. Israel Journal of Medical Sciences, 4, 883-894.
27. Laron, Z., Pertzelan, A., Karp, M., Kowadlo-Silbergeld, A. & Daughaday, W.H. (1971) Administration of growth hormone to patients with familial dwarfism with high plasma immunoreactive growth hormone. Measurement of sulfation factor, metabolic and linear growth responses. Journal of Clinical Endocrinology and Metabolism 33, 332-342.
28. Laron, Z., Pertzelan, A. & Mannheimer, S. (1966) Genetic pituitary dwarfism with high serum concentration of growth hormone. A new inborn error of metabolism? Israel Journal of Medical Sciences, 2, 153-155.
29. Laron, Z. & Sarel, R. (1970) Penis and testicular size in patients with growth hormone insufficiency. Acta Endocrinologica, 163, 625-633.
30. Laron, Z., Sarel, R. & Pertzelan, A. (1980) Puberty in Laron type dwarfism. European Journal of Pediatrics, 134, 79-83.
31. Lashansky, G., Saenger, P., Fishman, K., Gautier, T., Mayes, D., Berg, G., Di Martino-Nardi, J. & Retter, E. (1991) Normative data for adrenal steroidogenesis in a healthy pediatric population: age and sex related changes after adrenocorticotropin stimulation. Journal of Clinical Endocrinology and Metabolism, 73, 674-686.
32. Malozowski, S., Tanner, L., Wysowski, D. & Fleming, G. (1993) Growth hormone, insulin-like growth factor I and benign intracranial hypertension. New England Journal of Medicine, 329, 65-66.
33. Meacham, L.R., Murphy, T.C., Klinger, B., Erster, B., Laron, Z. & Parks, J.S. (1990) Heterogeneity of molecular defects causing Laron type dwarfism. (Abst. 1393). Proceedings of the Annual Meeting of the American Endocrine Society, Atlanta, GA, USA, pp. 373.
34. Niwa, M., Sato, Y., Saito, Y., Uchiyama, F., Ono, H., Yamashita, M., Kitaguchi, T., Shiga, Y., Notani, J., Yamada, H., Ishii, Y., Ueda, I. & Takagi, Y. (1986) Chemical synthesis, cloning and expression of genes for human somatomedin C (insulin like growth factor I) and 59Val somatomedin C. Annals of the New York Academy of Science, 469, 31-52.
35. Nobels, F. & Dewailles, D. (1992) Puberty and polycystic ovarian syndrome: the insulin/insulin-like growth factor I hypothesis. Fertility and Sterility, 58, 655-666.
36. Noll, K., Wegmann, B.R., Havemann, K. & Jaques, G. (1996) Insulin-like growth factors stimulate the release of insulin-like growth factor binding protein-3 (IGFBP-3) and degradation of IGFBP-4 in nonsmall cell lung cancer cell lines. Journal of Clinical Endocrinology and Metabolism, 81, 2653-2662.
37. Pertzelan, A., Lazar, L., Klinger, B. & Laron, Z (1993) Puberty in 15 patients with Laron Syndrome: a longitudinal study. In Lessons from Laron Syndrome (LS) 1966-1992. A model of GH and IGF-I action and interaction (eds. Z. Laron & J.S. Parks). Pediatric and Adolescent Endocrinology, 24, 27-33.
38. Poretsky, L., Glover, B., Laumas, V., Kalan, M. & Dunaif, A. (1988) The effects of experimental hyperinsulinemia on steroid secretion, ovarian [125 I] insulin, binding and ovarian [125 I] insulin-like growth factor I binding in the rat. Endocrinology, 122, 581-585.
39. Ranke, M.B., Savage, M.D., Chatelain, P.G., Preece, M.A., Blum, W.F., Wilton, P. (for the Pharmacia Study Group on Insulin-Like Growth Factor I Treatment in Growth Hormone Insensitivity Syndromes). (1995) Insulin-like growth factor (IGF-I) improves height in growth hormone insensitivity: two years results. Hormone Research, 44, 253-264.
40. Ranke, M.B. & Wilton, P. (1994) Adverse events during treatment with recombinant insulin-like growth factor I in patients with growth hormone insensitivity. Acta Paediatrica, (suppl 399), 143-145.
41. Schalch, D.S., Turman, N.Y., Marcsisin, V.S., Hefferman, M. & Guler, H.P. (1993) Short-term effects of recombinant human insulin-like growth factor I on metabolic control of patients with type II diabetes mellitus. Journal of Clinical Endocrinology and Metabolism, 77, 1563-1568.
42. Scharf, J.R., Ramadori, G., Braulke, T. & Hartmann, H. (1996) Synthesis of insulin-like growth factor binding proteins and of the acid-labile subunit in primary cultures of rat hepatocytes, of kupffer cells, and in co-cultures: regulation by insulin, insulin-like growth factor and growth hormone. Hepatology, 23, 818-827.
43. Silbergeld, A., Litwin, A., Bruchis, S., Varsano, I. & Laron, Z. (1986) Insulin-like growth factor (IGF-I) in healthy children, adolescents and adults as determined by a radioimmunoassay specific for the synthetic 53-70 peptide region. Clinical Endocrinology, 25, 67-74.
44. Uchijima, Y., Takenaka, A., Takahashi, S. & Noguchi, T. (1995) Production of insulin-like growth factors and their binding proteins in primary cultures of rat liver parenchymal and nonparenchymal cells. Biosci Biotechnol Biochem, 59, 1503-1515.
45. Willis, D., Mason, H., Gilling-Smith, C. & Franks, S. (1996) Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries. Journal of Clinical Endocrinology and Metabolism, 81, 302-309.
46. Zenobi, P.D., Hussain, M.A. & Lehinann, R. (1992) Insulin demand in type I diabetes mellitus is reduced during administration of insulin-like growth factor I. (Abst #A56. Diabetologia, (suppl. 1.) 35, 249.